BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5680391)

  • 1. The chances of genetic damage in the progeny of a woman treated with 131-I. I. Clinical problem and estimation of radiation dose to the gonads.
    Hennemann G; Mellink JH
    Folia Med Neerl; 1968; 11(2):40-7. PubMed ID: 5680391
    [No Abstract]   [Full Text] [Related]  

  • 2. The chances of genetic damage in the progeny of a woman treated with 131-I. II. Evaluation of the genetic risks.
    Sobels FH
    Folia Med Neerl; 1968; 11(2):48-52. PubMed ID: 4971382
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperthyroidism and radioiodine therapy].
    Annee Endocrinol; 1967; 19():25-36. PubMed ID: 4873363
    [No Abstract]   [Full Text] [Related]  

  • 4. Estimation of the genetic risk resulting from the treatment of women with 131-Iodine.
    Sobels FH
    Strahlentherapie; 1969 Aug; 138(2):172-7. PubMed ID: 5355728
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiation sickness after therapeutic administration of 806 mCi of 131I for thyroid cancer.
    Silink K; Nĕmec J; Kubal J; Röhling S; Vohnout S
    Nucl Med (Stuttg); 1967 Jul; 6(2):170-83. PubMed ID: 5593052
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytogenetic and clinical studies in children whose parents have been treated with iodine isotopes].
    Wicklund H; Einhorn J; Hulten M; Lindsten J; Zetterqvist P
    Nord Med; 1971 May; 85(20):629. PubMed ID: 5104042
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of 131 I radioiodine treatment during various thyroid diseases on the lymphocyte karyotype (preliminary results)].
    Blein JP; Garnier D; Maraud R
    Ann Endocrinol (Paris); 1972; 33(3):231-41. PubMed ID: 4650583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hematologic changes in the treatment of thyrotoxicosis and cancer of the thyroid gland with radioactive iodine 131-I].
    Nĕmec J; Neradilová M; Zamrazil V; Vohnout S
    Cas Lek Cesk; 1968 Jun; 107(25):742-8. PubMed ID: 5664846
    [No Abstract]   [Full Text] [Related]  

  • 9. [The survival of patients with thyroid cancers treated with radioactive iodine. Apropos of 147 cases followed up for more than 5 years].
    Tubiana M; Perez R; Parmentier C; Monnier JP
    Presse Med (1893); 1968 Nov; 76(42):1999-2002. PubMed ID: 5724625
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of the peripheral blood picture and the plasma protein fractions after therapeutic radioisotope incorporation].
    Pfannenstiel P
    Strahlenschutz Forsch Prax; 1969; 9():49-66. PubMed ID: 5371254
    [No Abstract]   [Full Text] [Related]  

  • 11. [Later results in thyroid cancers treated with radioactive iodine].
    Tubiana M; Vallee G; Perez R; Pignataro E
    Nucl Med (Stuttg); 1965; 2():367-79. PubMed ID: 5888968
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioisotope therapy of thyroid gland carcinoma].
    Höfer R
    Wien Klin Wochenschr; 1971 Jul; 83(27):512-3. PubMed ID: 5123477
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute radiation oedema of perithyroid tissues--a serious complication of the treatment of thyroid disorders with high doses of radioiodine.
    Höschl R; Nemec J; Silink K; Kubal J
    Nucl Med (Stuttg); 1965 Dec; 5(1):68-75. PubMed ID: 5868783
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with I-131 the therapy of thyroid cancer].
    Oyamada H; Taketa C; Yui N; Shimosato Y
    Rinsho Hoshasen; 1969 Jan; 14(1):50-63. PubMed ID: 5192442
    [No Abstract]   [Full Text] [Related]  

  • 15. RADIATION HAZARDS RESULTING FROM CLINICAL USE OF RADIO-IODINE.
    SEAR R
    Acta Radiol Ther Phys Biol; 1964 Aug; 2():263-72. PubMed ID: 14203055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thyroid carcinoma].
    Freyschmidt P; Franke H; Häring R
    Dtsch Med J; 1967 Sep; 18(18):542-7. PubMed ID: 5613630
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is a roentgen examination dangerous?].
    Pape R
    Wien Klin Wochenschr; 1965 Jul; 77(29):518-21. PubMed ID: 5836843
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the study of factors determining the efficacity of the treatment of thyroid gland cancer with I-131].
    Ivanitskaia VI; Stratienko VA
    Med Radiol (Mosk); 1968 Apr; 13(4):45-9. PubMed ID: 5658001
    [No Abstract]   [Full Text] [Related]  

  • 19. Criteria for selecting thyroid cancers as suitable for radioiodine treatment.
    Pochin EE
    Indian J Cancer; 1970 Sep; 7(3):191-9. PubMed ID: 5508528
    [No Abstract]   [Full Text] [Related]  

  • 20. Body distribution of Lipiodol 131-J following intralymphatic radiotherapy.
    Fava G; Roncoroni L
    Nucl Med (Stuttg); 1965 Dec; 5(1):1-11. PubMed ID: 4287956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.